These results altogether suggest that CXCL13–CXCR5-mediated interactions between TFH–B and TRM–B cells scaffold TFH–B–TRM lymphocyte cooperation in TLS for antitumor immunity in lung cancer as summarized in Fig. 6f. This evidence concerns the gene CXCL13 and lung carcinoma.